Other or ill-defined heart diseases

I9_OTHILLHEART

heart disease: A disease involving the heart and/or pericardium.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I51, I52* Hospital discharge: ICD-9 — 429 Hospital discharge: ICD-8 — 42899\|42999 Cause of death: ICD-10 — I51, I52* Cause of death: ICD-9 — 429 Cause of death: ICD-8 — 42899\|42999 2 out of 7 registries used, show all original rules.	2811
4. Check minimum number of events None	2811
5. Include endpoints None	2811
6. Filter based on genotype QC (FinnGen only)	2466

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	I9_OTHILLHEART
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I5[1-2]
HD_ICD_9	429
HD_ICD_8	42899\|42999
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I5[1-2]
COD_ICD_9	429
COD_ICD_8	42899\|42999
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other or ill-defined heart diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	33677	12205	20779
Only index persons	17579	6000	11579
Unadjusted period prevalence (%)
Whole population	0.50	0.35	0.58
Only index persons	0.37	0.22	0.44
Median age at first event (years)
Whole population	58.86	65.01	55.08
Only index persons	51.92	58.39	48.57

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2466	920	1546
Unadjusted period prevalence (%)	0.57	0.33	0.71
Median age at first event (years)	56.35	56.44	56.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2536: Matched controls
25352

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

91.6

311.1

163

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

311.0

292

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

6.1

307.7

877

2035

B01AA03

ATC

warfarin; systemic

8.6

307.7

668

1010

207

Kela drug reimbursment

Chronic arrhythmias

184.0

307.7

403

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

88.5

307.7

181

I48

ICD-10 Finland

Atrial fibrillation and flutter

102.4

307.7

585

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

169.5

307.7

259

I50.0

ICD-10 Finland

Congestive heart failure

172.5

307.7

304

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

7.5

307.7

864

1638

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

369.9

307.7

323

C01AA05

ATC

digoxin; systemic

17.8

307.7

282

177

201

Kela drug reimbursment

Chronic cardiac insufficiency

23.5

307.7

333

162

I51.7

ICD-10 Finland

Cardiomegaly

+∞

307.7

590

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

9.2

307.7

822

1259

I50.9

ICD-10 Finland

Heart failure, unspecified

75.0

307.7

535

I51.4

ICD-10 Finland

Myocarditis, unspecified

7260.2

307.7

956

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

81.9

289.6

154

I50.1

ICD-10 Finland

Left ventricular failure

1029.8

287.1

276

C03CA01

ATC

furosemide; systemic

4.5

274.5

960

3035

C07AB07

ATC

bisoprolol; oral

4.1

273.5

1391

5747

C03DA01

ATC

spironolactone; oral

6.5

246.1

454

826

XF404

NOMESCO Finland

Ambulatory ECG

10.6

230.8

264

274

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

49.7

212.0

123

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

311.4

199.2

200

K78

ICPC

Atrial fibrillation/flutter

18.7

198.8

160

I51.9

ICD-10 Finland

Heart disease, unspecified

666.4

190.5

186

TFP20

NOMESCO Finland

Cardiodefibrillation

287.0

184.4

186

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

+∞

180.4

171

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.0

168.7

573

1708

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

160.1

152

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

1643.3

156.9

151

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

6.4

155.1

273

467

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

330.4

153.5

154

B01AF02

ATC

apixaban; oral

6.6

153.1

261

432

AN1

Coronary angiography

4.9

152.5

371

852

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

149.4

1322

6922

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

7.5

148.1

222

320

I35.0

ICD-10 Finland

Aortic (valve) stenosis

25.3

144.8

102

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

63.5

144.5

250, ,

Kela drug reimbursment

61.9

140.3

I49.3

ICD-10 Finland

Ventricular premature depolarization

9.4

137.4

168

189

I51.8

ICD-10 Finland

Other ill-defined heart diseases

+∞

132.4

126

I48.1

ICD-10 Finland

Persistent atrial fibrillation

67.3

131.3

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

649.5

126.5

124

I34.1

ICD-10 Finland

Mitral (valve) prolapse

68.8

122.6

R07.4

ICD-10 Finland

Chest pain, unspecified

2.8

120.9

836

3758

I50

ICD-10 Finland

Heart failure

26.8

120.5

C01BD01

ATC

amiodarone; systemic

158.7

115.3

121

GD1LA

NOMESCO Finland

43.6

113.9

42999

ICD-8 Finland

Ill-defined heart disease, Other and unspecified heart disease

+∞

108.1

103

I47.1

ICD-10 Finland

Supraventricular tachycardia

25.2

108.0

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

539.7

105.5

104

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

104.4

497

1801

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

4.6

103.2

267

638

I51.1

ICD-10 Finland

Rupture of chordae tendineae, not elsewhere classified

+∞

101.7

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

5.2

100.1

219

455

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.8

98.9

613

2567

C09AA05

ATC

ramipril; oral

2.7

96.2

683

3062

XF402

NOMESCO Finland

ECG with work load test

4.1

94.1

283

757

I47.2

ICD-10 Finland

Ventricular tachycardia

201.5

94.0

I48.2

ICD-10 Finland

Chronic atrial fibrillation

480.0

93.9

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

130.0

93.7

100

R06.0

ICD-10 Finland

Dyspnoea

2.6

92.1

701

3242

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

91.2

ZXD05

NOMESCO Finland

Urgent procedure

2.4

85.5

823

4222

I44.2

ICD-10 Finland

Atrioventricular block, complete

856.1

85.1

FL1AC

NOMESCO Finland

Left cardioangiography

12.5

81.6

I49.5

ICD-10 Finland

Sick sinus syndrome

119.5

75.3

TFP34

NOMESCO Finland

Electrophysiological investigation

257.5

73.8

WX892

NOMESCO Finland

Monitored bed care

3.9

73.7

236

657

K77

ICPC

Heart failure

27.7

72.0

C07AA07

ATC

sotalol; systemic

8.0

70.8

125

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

6.8

69.9

111

169

Angiography of the heart and coronary arteries

4.3

67.2

182

448

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

63.8

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

8.7

63.3

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

7.4

63.3

130

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

28.4

62.2

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

601.8

60.0

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.9

59.9

136

290

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

59.6

WX872

NOMESCO Finland

Intensive care

4.5

57.5

145

337

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

92.3

57.1

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

56.8

707

3921

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

7.7

56.5

107

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

53.3

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

53.3

42899

ICD-8 Finland

Other myocardial insufficiency

+∞

53.3

TK800

NOMESCO Finland

Hemodialysis

6.7

53.3

133

A12BA01

ATC

potassium chloride; oral

4.6

52.6

127

285

I51.5

ICD-10 Finland

Myocardial degeneration

+∞

52.3

C09DX04

ATC

valsartan and sacubitril; oral

+∞

51.2

I25.2

ICD-10 Finland

Old myocardial infarction

3.5

51.1

187

567

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

51.0

576

3061

C01BC04

ATC

flecainide; systemic

112.4

51.0

C07AB02

ATC

metoprolol; systemic

2.3

50.8

463

2258

AP1

Catheterization of the left side of the heart

9.7

50.5

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

50.2

4298A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[ASTHENIA VASOREGULATORIA]

+∞

50.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.3

50.0

199

636

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

49.1

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

132.6

48.9

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.3

48.9

449

2193

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

48.4

407

1915

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

48.3

181

557

I51.0

ICD-10 Finland

Cardiac septal defect, acquired

+∞

48.1

XF640, ,

NOMESCO Finland

8.0

47.8

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

7.6

47.6

L04AA06

ATC

mycophenolic acid; systemic

6.0

46.6

142

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.1

46.1

200

673

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

46.0

K84

ICPC

Heart disease other

6.4

45.8

121

I20.09

ICD-10 Finland

Unstable angina

3.7

45.5

153

438

C01DA14

ATC

isosorbide mononitrate; oral

2.4

45.5

370

1712

XFE00

NOMESCO Finland

Epicardial ultrasonography

7.8

45.1

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.9

45.0

140

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.9

45.0

140

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

159.5

44.9

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

99.9

44.9

I44.1

ICD-10 Finland

Atrioventricular block, second degree

122.2

44.9

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

9.8

44.8

TFJ02

NOMESCO Finland

Muscle biopsy of heart

445.2

44.4

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

43.9

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

43.9

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

12.5

43.6

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

9.6

43.4

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.7

43.3

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

434.8

43.3

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5.4

43.2

167

5253

FHL

Cardiac lung machine

12.5

42.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

42.5

297

1282

127

Kela drug reimbursment

Transplant complication

6.5

42.3

108

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

41.9

428

2172

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

40.8

523

2888

4294A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Functional disturbances following cardiac surgery

+∞

40.7

AA1AD

NOMESCO Finland

CT of head and brain

1.9

39.3

663

4011

H02AB06

ATC

prednisolone; systemic

1.7

39.2

1101

7750

C08DA01

ATC

verapamil; systemic

4.4

38.5

229

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

37.7

338

1623

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

36.5

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

36.4

268

1182

R00.0

ICD-10 Finland

Tachycardia, unspecified

4.1

35.7

101

256

M04AA01

ATC

allopurinol; systemic

2.3

35.4

305

1439

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.6

35.4

225

926

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

35.0

450

2474

R02

ICPC

Shortness of breath/dyspnoea

2.3

34.5

296

1393

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

341.6

34.0

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.9

33.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

33.7

113

323

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

50.7

33.5

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

33.4

AS4

Physiological pacemaker insertion DDD (R)

+∞

33.4

R07.3

ICD-10 Finland

Other chest pain

2.3

33.1

260

1178

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.9

33.0

156

TFP35

NOMESCO Finland

Electroanatomical mapping

118.2

32.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

32.6

146

499

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

37.9

32.5

L04AX01

ATC

azathioprine; systemic

3.2

32.3

130

417

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.3

32.1

205

ZX120

NOMESCO Finland

Intravenous

2.4

32.1

233

1019

Z2221

NOMESCO Finland

Medical doctor

1.8

31.3

603

3763

R4110

NOMESCO Finland

Physiotherapy

1.8

31.3

627

3959

R50.9

ICD-10 Finland

Fever, unspecified

2.0

31.2

383

2067

L04AD02

ATC

tacrolimus; systemic

6.6

31.1

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

5.4

31.1

118

B33.2

ICD-10 Finland

Viral carditis

70.8

30.9

Z94.0

ICD-10 Finland

Kidney transplant status

6.5

30.7

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

30.3

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

30.2

237

1073

K80

ICPC

Cardiac arrhythmia NOS

2.9

29.9

149

541

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

8.6

29.6

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

3.9

29.3

224

N18.8

ICD-10 Finland

Other chronic renal failure

4.9

29.3

136

ZXE00

NOMESCO Finland

One hour or less

1.7

28.9

834

5791

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.9

28.4

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.7

28.2

244

N05CF01

ATC

zopiclone; oral

1.7

28.2

743

5034

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

28.2

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

28.2

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

39.4

28.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

27.9

196

844

B01AB05

ATC

enoxaparin; parenteral

1.7

27.9

639

4170

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

284.5

27.8

B01AF03

ATC

edoxaban; oral

11.3

27.6

PD5AD

NOMESCO Finland

CT of aorta

5.0

27.5

120

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.7

27.3

245

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

27.1

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.9

27.1

128

451

A11CC03

ATC

alfacalcidol; systemic

4.5

26.9

150

I44.0

ICD-10 Finland

Atrioventricular block, first degree

10.8

26.9

N05BA01

ATC

diazepam; systemic, rectal

2.0

26.9

316

1674

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.4

26.8

100

A02BC02

ATC

pantoprazole; systemic

1.6

26.8

1513

12251

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

9.5

26.2

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

26.1

H02AB04

ATC

methylprednisolone; systemic

2.0

25.8

322

1740

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

25.8

225

1063

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

25.6

298

1572

L04AD01

ATC

ciclosporin; systemic

4.7

25.5

128

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.9

25.5

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

4.9

25.3

117

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

25.3

113

386

A12AA04

ATC

calcium carbonate; oral

5.5

25.3

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

25.0

4298X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[MORBUS CORDIS ALIA DEFINITA]

+∞

25.0

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

24.8

123

N18.0

ICD-10 Finland

End-stage renal disease

8.1

24.8

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

24.5

618

4114

B01AE07

ATC

dabigatran etexilate; oral

4.5

24.3

137

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.2

24.3

320

K70.0

ICD-10 Finland

Alcoholic fatty liver

6.6

24.3

Z3231

NOMESCO Finland

Registered nurse

1.7

24.2

599

3969

PD5BD

NOMESCO Finland

Extensive CT of aorta

5.6

24.1

J01MA12

ATC

levofloxacin; systemic

1.8

23.9

410

2452

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

242.1

23.7

R03AC02

ATC

salbutamol; inhalant

1.5

23.6

1174

9137

Z94.1

ICD-10 Finland

Heart transplant status

47.1

23.3

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

7.1

23.3

N02AX02

ATC

tramadol; systemic, rectal

1.5

23.3

954

7111

R00.2

ICD-10 Finland

Palpitations

2.5

23.1

152

634

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

23.0

141

569

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

22.9

1CX08, ,

NOMESCO Finland

65.6

22.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

22.6

678

4701

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.3

22.5

263

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

5.1

22.3

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

22.2

240

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.4

22.1

152

647

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

21.9

AQ1

Conventional electrophysiological examination

+∞

21.9

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

21.9

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

21.8

223

1120

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

25.3

21.7

I40.8

ICD-10 Finland

Other acute myocarditis

221.8

21.6

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

221.8

21.6

J01FF01

ATC

clindamycin; systemic

1.6

21.6

569

3815

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.4

425

2645

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

21.2

408

2516

N05BA04

ATC

oxazepam; oral

1.6

21.1

581

3935

WX730

NOMESCO Finland

Conventional respirator

5.3

21.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

21.1

233

1204

H02AB07

ATC

prednisone; oral

1.9

21.1

302

1705

AP4

Myocardial biopsy

+∞

20.9

I40.0

ICD-10 Finland

Infective myocarditis

+∞

20.9

I49.1

ICD-10 Finland

Atrial premature depolarization

5.0

20.7

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

20.6

473

3058

R55

ICD-10 Finland

Syncope and collapse

2.0

20.5

237

1243

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

20.5

239

1258

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.9

20.5

348

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

4.2

20.3

127

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

20.2

779

5690

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.5

20.2

200

R00.1

ICD-10 Finland

Bradycardia, unspecified

4.1

20.2

136

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

19.9

230

1206

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.5

19.9

128

529

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

19.8

107

405

N19

ICD-10 Finland

Unspecified kidney failure

3.1

19.7

269

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

8.2

19.6

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

6.2

19.4

K83

ICPC

Heart valve disease NOS

46.4

19.2

3AC01, ,

NOMESCO Finland

5.9

19.2

E66.8

ICD-10 Finland

Other obesity

2.6

19.1

115

460

Z2446

NOMESCO Finland

Social worker

2.2

19.0

157

724

Electrophysiological Special Examination

+∞

18.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.8

376

2340

E66.0

ICD-10 Finland

Obesity due to excess calories

6.6

18.7

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.3

18.7

142

632

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

18.6

144

646

SPAT1097

SPAT

Recording of ECG

1.9

18.3

268

1520

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

18.3

149

684

I45.9

ICD-10 Finland

Conduction disorder, unspecified

44.3

18.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

18.2

K99

ICPC

Cardiovascular disease other

4.0

18.2

129

R53

ICD-10 Finland

Malaise and fatigue

1.6

18.1

520

3544

I20.00

ICD-10 Finland

Unstable angina

3.4

17.8

192

5314

FHL

Bypass surgery for four or more vessels

7.3

17.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

17.8

209

1103

I51.6

ICD-10 Finland

Cardiovascular disease, unspecified

+∞

17.7

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

17.7

I30.0

ICD-10 Finland

Acute nonspecific idiopathic pericarditis

+∞

17.7

4299X

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Heart disease, unspecified

+∞

17.7

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.1

17.7

254

B01AC04

ATC

clopidogrel; oral

1.7

17.7

321

1942

R03BB04

ATC

tiotropium bromide; inhalant

2.0

17.7

216

1155

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.8

17.4

J46

ICD-10 Finland

Status asthmaticus

3.4

17.4

185

A46

ICD-10 Finland

Erysipelas

1.8

17.4

306

1834

WX882

NOMESCO Finland

High dependency care

3.3

17.2

201

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

17.2

412

2683

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

17.2

154

735

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

17.1

296

1765

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

3.1

16.8

235

C07AG02

ATC

carvedilol; oral

2.4

16.8

116

496

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.3

16.7

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

16.7

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

16.7

4293A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Cardiomegaly

+∞

16.7

C08DB01

ATC

diltiazem; oral

2.5

16.7

109

454

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

16.7

107

442

Catheterization and pressure measurement of the left side of the heart

4.5

16.6

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

16.4

16.5

I48.3

ICD-10 Finland

Typical atrial flutter

171.0

16.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

16.4

685

5047

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

16.3

334

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

16.2

179

923

C09AA02

ATC

enalapril; systemic

1.6

16.2

397

2596

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

16.2

400

K29

ICPC

Cardiovascular sympt/complt other

2.7

16.1

336

R04.0

ICD-10 Finland

Epistaxis

2.1

16.1

150

727

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.2

15.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

15.7

289

J01FA06

ATC

roxithromycin; oral

1.4

15.6

810

6211

L04AA01

ATC

[U] ciclosporin

4.8

15.6

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

+∞

15.6

I42

ICD-10 Finland

Cardiomyopathy

+∞

15.6

XF409

NOMESCO Finland

Other special ECG

26.4

15.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

15.6

134

629

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

160.9

15.5

J01MA14

ATC

moxifloxacin; systemic

1.9

15.4

194

1048

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.0

15.4

237

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

15.4

155

WX722

NOMESCO Finland

PEEP

2.5

15.3

386

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

15.3

108

466

5315

FHL

Bypass surgery using a mammary artery

5.5

15.2

137

Kela drug reimbursment

Uraemia requiring dialysis

5.5

15.2

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

15.2

711

5344

A11

ICPC

Chest pain NOS

2.0

15.1

177

933

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

15.0

513

3618

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.5

14.9

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.5

14.9

398

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

14.8

731

5544

M10.9

ICD-10 Finland

Gout, unspecified

2.1

14.8

136

656

C10AA01

ATC

simvastatin; oral

1.4

14.6

824

6399

N05CD07

ATC

temazepam; oral

1.7

14.6

262

1576

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

14.6

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

14.6

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

14.6

A10BK01

ATC

dapagliflozin; oral

2.0

14.6

150

755

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.8

14.5

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

150.8

14.5

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

14.5

197

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

14.5

128

608

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

3.5

14.4

142

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.9

14.3

202

1132

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.7

14.2

287

J01AA02

ATC

doxycycline; systemic

1.4

14.2

1695

14922

Z3226

NOMESCO Finland

Physiotherapist

1.6

14.1

361

2380

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

14.1

164

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.7

14.0

205

Kela drug reimbursment

Chronic hypertension

1.5

13.9

545

3945

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

13.9

423

R03BA01

ATC

beclometasone; inhalant

1.7

13.9

275

1701

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

13.8

223

1302

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

13.7

116

541

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

13.6

176

958

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

13.6

122

583

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

13.5

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

13.5

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

13.5

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

+∞

13.5

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

13.5

AS2

Ventricular pacemaker insertion VVI (R)

+∞

13.5

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

13.5

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

13.5

I31.8

ICD-10 Finland

Other specified diseases of pericardium

+∞

13.5

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

13.5

WX002

NOMESCO Finland

Sedation and analgesia

1.6

13.4

367

2457

J96.1

ICD-10 Finland

Chronic respiratory failure

3.3

13.4

154

N05AA02

ATC

levomepromazine; systemic

2.3

13.4

105

475

B01AC06

ATC

acetylsalicylic acid; oral

2.6

13.3

291

UJF32

NOMESCO Finland

Coloscopy

1.5

13.3

507

3649

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.3

13.2

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

13.2

112

WX213

NOMESCO Finland

Lower leg blockade

5.9

13.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.8

13.0

216

1271

R07.2

ICD-10 Finland

Precordial pain

3.3

13.0

152

B01AF01

ATC

rivaroxaban; oral

1.8

12.8

185

1044

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

12.8

149

784

K07

ICPC

Swollen ankles/oedema

2.4

12.8

370

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

12.7

404

2797

J01CA04

ATC

amoxicillin; systemic

1.4

12.7

1807

16205

K01

ICPC

Heart pain

4.4

12.6

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

12.6

354

2384

WX890

NOMESCO Finland

Intesive care monitoring

6.0

12.6

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

12.5

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

+∞

12.5

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

12.5

342

Kela drug reimbursment

Dronedarone

+∞

12.5

I40

ICD-10 Finland

Acute myocarditis

130.6

12.4

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.0

12.4

126

631

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

12.3

366

2494

C08CA05

ATC

nifedipine; systemic

2.0

12.3

126

633

S97

ICPC

Chronic ulcer skin

2.1

12.3

118

579

AP2

Catheterization of the right side of the heart

37.7

12.2

FM1AD

NOMESCO Finland

CT of heart

37.7

12.2

N06AB04

ATC

citalopram; systemic

1.5

12.2

421

2964

G47.3

ICD-10 Finland

Sleep apnoea

1.5

12.1

463

3327

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

11.1

12.0

A98

ICPC

Health maint/preventive medicine

0.7

12.0

1961

21039

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

11.8

1018

8410

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

11.7

120

604

Coronary artery bypass surgery

3.2

11.7

147

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.6

11.6

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

23.0

11.6

C07AA05

ATC

propranolol; systemic

1.5

11.5

365

2520

R07.1

ICD-10 Finland

Chest pain on breathing

3.4

11.5

123

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

11.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

11.5

7AX01, ,

NOMESCO Finland

+∞

11.5

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

11.5

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

11.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

11.4

549

4114

A02BC03

ATC

lansoprazole; oral

1.4

11.4

560

4214

R11

ICD-10 Finland

Nausea and vomiting

1.8

11.4

173

992

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

11.4

468

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

11.4

193

1143

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.3

11.4

129

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

11.3

430

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

9.6

11.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.3

11.2

130

N06AX11

ATC

mirtazapine; oral

1.4

11.2

688

5376

Q21.10

ICD-10 Finland

Persistent ostium secundum

17.1

11.2

J01DA01

ATC

[U] cefalexin

1.3

11.2

1319

11375

N03AX16

ATC

[U] pregabalin

1.5

11.2

428

3073

B05DB

ATC

Hypertonic solutions

5.3

11.1

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

11.0

126

659

N17.8

ICD-10 Finland

Other acute renal failure

4.4

11.0

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.4

11.0

308

A10AC01

ATC

insulin (human); parenteral

1.8

10.9

159

900

A02BC01

ATC

omeprazole; systemic

1.4

10.9

523

3915

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

10.9

309

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

10.8

1078

9056

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

10.8

114

580

J01DB01

ATC

cefalexin; oral

1.4

10.7

1805

16349

F19.0

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, acute intoxication

28.1

10.7

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

28.1

10.7

FN1AD

NOMESCO Finland

CT of coronary arteries

3.5

10.7

104

ZX108

NOMESCO Finland

Inhalation

5.3

10.6

I20.01

ICD-10 Finland

Unstable angina

2.8

10.6

189

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

10.5

239

1529

C02EA02, ,

ATC

2.2

10.5

423

I45.6

ICD-10 Finland

Pre-excitation syndrome

110.4

10.4

I45.3

ICD-10 Finland

Trifascicular block

110.4

10.4

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

10.4

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

10.4

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

10.4

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

10.4

Initial pacemaker installation

+∞

10.4

Initial installation of the atrial pacemaker

+∞

10.4

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

10.4

AS7

Arrhythmia pacemaker insertion VVI (R) S

+∞

10.4

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

+∞

10.4

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.4

10.4

111

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

10.4

284

1899

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

3.1

10.3

137

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.0

10.3

148

C09AA04

ATC

perindopril; oral

2.1

10.3

447

B01AB04

ATC

dalteparin; parenteral

2.1

10.2

468

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

10.2

245

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

10.2

198

1217

C10AA05

ATC

atorvastatin; oral

1.3

10.2

800

6479

R03BA05

ATC

fluticasone; inhalant

1.5

10.2

344

2407

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.4

10.1

283

B05DA

ATC

Isotonic solutions

4.6

10.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

10.0

855

7006

E86

ICD-10 Finland

Volume depletion

2.6

10.0

212

Catheterization and pressure measurement of the right side of the heart

40.2

10.0

SPAT1254

SPAT

Administration of medicine

1.6

9.9

273

1826

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.8

9.9

152

874

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

9.9

112

584

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.2

9.9

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.5

9.9

255

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.7

9.9

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

9.8

110

A02BC05

ATC

esomeprazole; systemic

1.3

9.8

773

6256

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

4.9

9.8

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

9.8

247

1621

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

9.7

127

696

R51.80

ICD-10 Finland

Headache

1.5

9.7

287

1952

R42

ICD-10 Finland

Dizziness and giddiness

1.4

9.7

420

3082

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

55.2

9.6

N05AH04

ATC

quetiapine; oral

1.5

9.6

371

2661

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

3.9

9.6

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

9.6

186

1144

Q23.11

ICD-10 Finland

Bicuspid aortic valve

11.4

9.6

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.8

9.5

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.1

9.5

407

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

9.5

155

909

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

100.4

9.4

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

100.4

9.4

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

100.4

9.4

V03AA01, ,

ATC

3.1

9.4

129

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

9.4

AC4

MVP

+∞

9.4

C01BD07

ATC

dronedarone; oral

+∞

9.4

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

9.4

I40.1

ICD-10 Finland

Isolated myocarditis

+∞

9.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

9.4

181

1111

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

9.4

124

K04

ICPC

Palpitations/awareness of heart

2.3

9.4

318

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

9.3

357

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.1

9.3

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.4

9.3

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

4.7

9.3

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.3

745

6036

I49

ICD-10 Finland

Other cardiac arrhythmias

3.8

9.2

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.1

9.2

120

JN4AD

NOMESCO Finland

Body CT examination

1.6

9.2

214

1377

AN3

Balloon angioplasty and metallic stent

2.6

9.2

198

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.1

732

5929

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.3

9.1

AA5PD

NOMESCO Finland

CT examination of brain pefusion

4.6

9.1

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

15.6

9.0

Q21.19

ICD-10 Finland

Atrial septal defect NOS

15.6

9.0

GD1UN

NOMESCO Finland

Lung circulation SPECT

10.1

9.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

9.0

171

J01FA10

ATC

azithromycin; systemic

1.3

9.0

1148

9896

XG466

NOMESCO Finland

Sleep oxymetry

2.5

9.0

230

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.3

8.9

305

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

8.9

397

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

8.9

404

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

24.1

8.9

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

8.9

553

4307

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.0

8.9

128

V03AE03

ATC

lanthanum carbonate; oral

10.7

8.8

J81

ICD-10 Finland

Pulmonary oedema

9.5

8.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

8.8

108

581

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.9

8.7

135

X58

ICD-10 Finland

Exposure to other specified factors

1.5

8.7

307

2164

R04.2

ICD-10 Finland

Haemoptysis

2.2

8.7

309

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

50.1

8.7

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

50.1

8.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

8.7

422

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

8.6

284

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

8.6

102

541

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

8.6

217

J01DA09

ATC

[U] cefadroxil

1.4

8.5

516

3998

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

8.5

432

3252

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

8.5

110

W19

ICD-10 Finland

Unspecified fall

1.6

8.5

200

1292

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

8.5

151

908

TK810

NOMESCO Finland

Hemofiltration

7.4

8.4

C03AA03

ATC

hydrochlorothiazide; oral

1.7

8.4

145

863

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.0

8.4

116

AP3

Catheterization of the right and left side of the heart

90.3

8.4

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

90.3

8.4

N05BA02

ATC

chlordiazepoxide; systemic

2.4

8.4

231

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

8.4

256

Z49.2

ICD-10 Finland

Other dialysis

4.3

8.4

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.1

8.4

353

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

8.4

A03

ICPC

Fever

1.4

8.3

332

2394

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.7

8.3

I51.2

ICD-10 Finland

Rupture of papillary muscle, not elsewhere classified

+∞

8.3

Catheter ablation of arrhythmia

+∞

8.3

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

8.3

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

8.3

4240B

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[PROLAPSUS VALVULAE MITRALIS (SYNDROMA BARLOW)]

+∞

8.3

Aortic Valve Replacement (AVR)

+∞

8.3

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

8.3

B04AB02, ,

ATC

2.8

8.3

144

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

3.0

8.3

117

XF620

NOMESCO Finland

Examination of circulation with color method

8.5

8.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

8.2

189

1212

C02AC05

ATC

moxonidine; oral

2.1

8.2

383

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.3

8.2

253

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

8.2

552

4349

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.6

8.1

A13

ICPC

Concern/fear medical treatment

2.8

8.1

135

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

8.1

200

1305

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

8.1

231

1557

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.8

8.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

8.1

249

1706

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

8.1

148

896

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

8.1

447

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

8.1

H02AB09

ATC

hydrocortisone; systemic

2.4

8.1

211

5CM18, ,

NOMESCO Finland

11.7

8.1

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

8.0

231

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

3.3

7.9

R4190

NOMESCO Finland

Nutritional therapy

2.0

7.9

382

132

Kela drug reimbursment

Sarcoidosis

4.6

7.9

K92.1

ICD-10 Finland

Melaena

1.8

7.8

106

588

J45

ICD-10 Finland

Asthma

1.6

7.8

180

1156

J01MA02

ATC

ciprofloxacin; systemic

1.3

7.8

785

6531

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

7.0

7.8

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

7.0

7.8

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.7

7.7

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

45.1

7.7

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

7.7

448

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.8

7.7

139

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

7.7

252

1750

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

7.7

273

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.5

7.6

C09AA01

ATC

captopril; oral

2.9

7.6

123

R80

ICD-10 Finland

Isolated proteinuria

4.0

7.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

7.6

500

ZXD00

NOMESCO Finland

Emergency procedure

2.2

7.5

263

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

7.5

349

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.9

7.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.4

791

6619

FFA10

NOMESCO Finland

Excision of lesion of atrium

80.3

7.4

E87.6

ICD-10 Finland

Hypokalaemia

2.1

7.4

297

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

7.4

512

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

7.7

7.4

B04AB01, ,

ATC

3.4

7.4

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.8

7.3

N02BE01

ATC

paracetamol; systemic, rectal

1.3

7.3

1939

18080

R03AC12

ATC

salmeterol; inhalant

1.9

7.3

449

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

7.3

174

1127

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

3.6

7.3

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

7.3

XFP02, ,

NOMESCO Finland

+∞

7.3

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

+∞

7.3

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

+∞

7.3

4298B

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Other ill-defined heart diseases[SPORT HEART]

+∞

7.3

5284

FHL

Mitral defect correction with flap prosthesis or graft

+∞

7.3

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

+∞

7.3

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

+∞

7.3

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

+∞

7.3

I30.8

ICD-10 Finland

Other forms of acute pericarditis

+∞

7.3

AQ2

Electrophysiological electroanatomical examination

+∞

7.3

4291A

ICD-9 Finland

Ill-defined descriptions and complications of heart disease, Myocardial degeneration

+∞

7.3

FXE00

NOMESCO Finland

Use of ECLA

+∞

7.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

7.3

457

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

2.9

7.3

110

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.8

7.3

121

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.2

7.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

7.2

158

1004

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.3

7.2

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

7.1

288

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

30.1

7.1

A02BA04

ATC

nizatidine; systemic

1.6

7.1

147

919

M05BA04

ATC

alendronic acid; oral

1.6

7.1

151

951

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

7.1

700

5793

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.3

7.1

224

78200

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Precordial pain

7.9

7.1

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.8

7.1

I97.0

ICD-10 Finland

Postcardiotomy syndrome

12.0

7.1

R03DA04

ATC

theophylline; systemic, rectal

1.7

7.0

112

653

J20

ICD-10 Finland

Acute bronchitis

1.6

7.0

180

1185

WX900

NOMESCO Finland

Resuscitation

10.0

7.0

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

10.0

7.0

N06AB03

ATC

fluoxetine; oral

1.5

7.0

216

1481

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.2

7.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

6.9

239

1676

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

6.9

443

3453

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

6.9

153

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.6

6.9

153

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

6.9

246

V03AE01

ATC

polystyrene sulfonate; oral

3.0

6.9

J01FA15

ATC

telithromycin; oral

1.6

6.9

169

1102

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

6.9

253

J94.8

ICD-10 Finland

Other specified pleural conditions

3.1

6.9

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.3

6.8

N05BA12

ATC

alprazolam; oral

1.5

6.8

180

1194

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

6.8

136

844

QDA10

NOMESCO Finland

Incision of skin of lower limb

4.1

6.8

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.8

6.8

120

WX740

NOMESCO Finland

Nitrogen oxide therapy

11.0

6.8

A10BK03

ATC

empagliflozin; oral

1.6

6.8

169

1107

N30.0

ICD-10 Finland

Acute cystitis

1.4

6.8

269

1939

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

40.1

6.8

I44.4

ICD-10 Finland

Left anterior fascicular block

40.1

6.8

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

4.3

6.7

C08CA02

ATC

felodipine; oral

1.6

6.7

158

1020

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.7

312

2310

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.8

6.7

100

572

G44.2

ICD-10 Finland

Tension-type headache

1.5

6.7

223

1552

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.2

6.7

WX402

NOMESCO Finland

General anaesthesia

1.4

6.7

396

3051

SPAT1263

SPAT

Sampling

1.3

6.7

756

6358

J01FA09

ATC

clarithromycin; systemic

1.3

6.7

561

4544

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

6.7

457

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

6.7

805

6823

N07BB01

ATC

disulfiram; oral

1.8

6.7

486

A02BA02

ATC

ranitidine; systemic

1.4

6.6

350

2648

4140X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]

5.9

6.6

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

12.3

6.6

C01BA03

ATC

disopyramide; systemic

12.3

6.6

C08CA01

ATC

amlodipine; oral

1.3

6.5

699

5838

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.0

6.5

SPAT1255

SPAT

Intravenous administration of medicine

1.7

6.5

111

662

K24

ICPC

Fear of heart disease

2.4

6.5

183

C08CA07

ATC

nisoldipine; oral

3.1

6.5

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

6.5

173

1152

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

6.4

159

N03AE01

ATC

clonazepam; systemic

1.7

6.4

109

648

WX902

NOMESCO Finland

External defibrillation of heart

70.0

6.4

5311

FHL

Bypass surgery in one vein

70.0

6.4

R03BA08

ATC

ciclesonide; inhalant

1.6

6.4

139

881

WNF00

NOMESCO Finland

Infection source and contact determination

7.4

6.4

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

14.3

6.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

6.4

268

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.0

6.4

K65.0

ICD-10 Finland

Acute peritonitis

3.0

6.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.0

6.3

C07AB03

ATC

atenolol; systemic

1.8

6.3

553

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

8.2

6.3

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

6.3

137

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

6.3

387

N05CF02

ATC

zolpidem; oral

1.4

6.3

300

2233

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

6.2

Cardiac muscle biopsy

+∞

6.2

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

+∞

6.2

AC2

MVR bio

+∞

6.2

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

6.2

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

6.2

4241A

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]

+∞

6.2

FE1AT

NOMESCO Finland

Pericardial puncture with ultrasound guidance

+∞

6.2

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

+∞

6.2

4271A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal ventricular tachycardia

+∞

6.2

4229X

ICD-9 Finland

Acute myocarditis, Other and unspecified acute myocarditis[MYOCARDITIS ACUTA NUD]

+∞

6.2

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

+∞

6.2

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

+∞

6.2

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

6.2

186

1267

R4120

NOMESCO Finland

Occupational therapy

1.7

6.2

116

708

N06AA12

ATC

doxepin; systemic

1.8

6.2

542

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.2

261

1902

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.5

6.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.9

6.2

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

5.3

6.1

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

2.4

6.1

169

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

6.1

110

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

6.1

139

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

6.1

201

KBV00

NOMESCO Finland

Insertion of stent into ureter

3.8

6.1

R60.0

ICD-10 Finland

Localized oedema

1.5

6.1

207

1449

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

12.5

6.1

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

6.1

145

941

N05AN01

ATC

lithium; oral

2.2

6.1

227

R03BA02

ATC

budesonide; inhalant

1.4

6.0

312

2351

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1147

3955

4.47

295.23

6.7

1.8

2054.99

535.13

ng/l

12.40

1028

3143

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

432

1096

4.54

157.19

3.0

1.8

10.41

6.01

ug/l

2.00

374

939

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

395

948

4.75

153.97

5.0

1.8

298.34

85.85

ng/l

9.18

367

829

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

788

3115

3.22

147.95

9.0

2.8

584.67

515.84

ng/l

0.25

707

2279

(3027456) Digoxin [Moles/volume] in Serum or Plasma

41.83

140.91

3.0

1.9

0.85

1.06

nmol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

236

399

6.42

135.25

4.3

1.8

11.36

11.05

mg/l

0.24

224

371

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1188

6433

2.59

117.43

7.1

2.7

417.92

54.13

ng/l

0.90

936

4291

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

203

355

6.13

112.08

6.7

2.8

0.34

0.32

iu/ml

0.43

135

169

(3032080) INR in Blood by Coagulation assay

1321

7659

2.51

111.00

26.9

5.8

1.41

1.09

inr

59.38

1136

6214

(3004789) Transferrin [Mass/volume] in Serum or Plasma

602

2506

2.84

98.14

4.1

2.2

2.25

2.32

g/l

2.35

564

2292

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

568

2299

2.89

97.54

4.1

2.3

22.61

24.30

2.03

534

2128

(3022948) Iron [Moles/volume] in Serum or Plasma

627

2688

2.77

96.44

4.1

2.3

12.47

13.94

umol/l

5.40

592

2480

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

626

2751

2.69

91.14

2.2

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

621

2742

2.67

89.36

6.3

3.4

0.82

mmol/l

0.15

587

2580

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

271

737

4.00

87.87

3.9

1.7

36.56

40.96

u/l

2.58

243

669

(3020779) Urea [Moles/volume] in Serum or Plasma

406

1469

3.10

84.33

16.4

6.3

10.58

8.53

mmol/l

5.89

383

1412

(3023368) Bacteria identified in Blood by Culture

914

4965

2.31

82.66

5.8

3.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

730

3781

2.31

72.18

3.0

1.6

1.21

1.23

mg/l

0.09

558

2871

(3018677) aPTT in Platelet poor plasma by Coagulation assay

538

2437

2.53

71.80

4.7

2.0

31.03

28.88

8.52

518

2376

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

382

4.73

71.39

1.5

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

444

1895

2.63

66.64

2.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

462

2017

2.58

66.15

2.1

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

166

388

4.51

65.45

1.6

1.7

—

(3019977) pH of Arterial blood

431

1852

2.60

63.59

12.6

7.2

7.42

0.16

233

1003

(3003396) Base excess in Arterial blood by calculation

425

1837

2.58

61.83

12.7

7.1

1.21

0.69

mmol/l

1.76

353

1493

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

434

1896

2.55

61.74

5.8

4.4

249.67

236.37

u/l

0.88

410

1795

(3027801) Oxygen [Partial pressure] in Arterial blood

427

1854

2.57

61.52

12.6

7.1

11.97

12.89

kpa

2.60

405

1787

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

427

1854

2.57

61.52

12.6

7.1

5.10

5.11

kpa

0.07

405

1784

(3003458) Phosphate [Moles/volume] in Serum or Plasma

482

2219

2.45

61.24

12.4

5.5

1.10

1.01

mmol/l

7.46

449

2059

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

155

377

4.31

58.00

1.8

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

169

440

4.04

57.73

2.1

1.6

0.23

0.24

g/l

0.71

159

421

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

173

460

3.96

57.40

2.0

1.6

1.16

1.21

g/l

1.06

164

438

(3000991) Gas panel - Venous blood

355

1458

2.67

57.03

15.3

7.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

123

253

5.06

56.53

1.6

1.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

146

350

4.36

55.65

1.8

1.5

145.67

155.70

au/ml

0.46

(3016502) Oxygen saturation in Arterial blood

378

1641

2.53

54.03

13.2

7.6

95.86

96.09

0.41

363

1587

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

884

5426

1.97

52.89

3.3

2.1

515.90

242.80

u/l

0.83

852

5148

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

189

581

3.43

50.53

4.5

2.0

1612.43

353.91

ug/l

0.85

183

553

(3012544) pH of Venous blood

370

1650

2.45

49.68

6.7

3.5

7.37

7.38

2.40

231

947

(3002173) Hemoglobin [Mass/volume] in Arterial blood

354

1558

2.48

48.86

14.0

7.9

122.56

124.09

g/l

0.65

346

1522

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1353

9711

1.84

48.49

8.5

6.5

12.88

11.90

umol/l

1.32

1295

9256

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

186

5.38

48.23

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

190

5.27

47.10

1.4

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

380

3.90

46.60

7.1

5.7

559.36

657.74

iu/ml

0.11

(3002032) Base excess in Venous blood by calculation

356

1605

2.42

46.49

6.8

3.6

1.78

1.76

mmol/l

0.04

323

1363

(3013826) Glucose [Moles/volume] in Serum or Plasma

1458

10790

1.83

46.44

9.0

4.3

6.80

6.71

mmol/l

0.67

1418

10179

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

146

401

3.80

46.17

1.5

1.3

248.67

248.36

u/ml

0.00

106

245

(3014576) Chloride [Moles/volume] in Serum or Plasma

457

2317

2.19

45.12

13.1

6.5

104.33

104.32

mmol/l

0.02

457

2317

(44790049) Parainfluenza type 3 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

190

5.15

45.05

1.4

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

1352

9837

1.80

45.00

9.9

6.3

1.89

1.96

e9/l

0.34

1194

8573

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1168

8139

1.81

44.95

12.8

5.7

1.20

1.21

mmol/l

7.11

1115

7487

(3006315) Basophils [#/volume] in Blood

1326

9595

1.80

44.93

10.0

6.2

0.04

e9/l

0.20

1150

8156

(3013115) Eosinophils [#/volume] in Blood

1359

9916

1.80

44.67

10.4

6.5

0.20

e9/l

0.01

1197

8557

(3001604) Monocytes [#/volume] in Blood

1322

9576

1.79

44.46

10.0

6.2

0.62

0.59

e9/l

4.39

1149

8128

(3021447) Carbon dioxide [Partial pressure] in Venous blood

358

1652

2.36

44.24

6.8

3.6

5.97

5.77

kpa

2.95

350

1605

(3010375) cycloSPORINE [Mass/volume] in Blood

8.43

43.73

26.6

28.9

101.45

127.07

ug/l

1.70

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

194

662

3.09

43.60

2.1

1.8

4.51

1.94

ug/l

0.43

185

594

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1279

9214

1.78

43.46

13.6

6.3

1.21

1.22

mmol/l

5.63

1136

7950

(3009445) Proteinase 3 Ab [Units/volume] in Serum

198

685

3.05

43.45

1.8

1.7

7.25

11.72

iu/ml

—

(3006504) Eosinophils/Leukocytes in Blood

1233

8803

1.78

43.08

10.2

6.5

2.80

2.90

0.79

1192

8218

(3019069) Monocytes/Leukocytes in Blood

1235

8823

1.78

43.04

10.3

6.6

9.06

8.90

1.21

1194

8245

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

285

4.22

42.76

3.2

3.4

20936.20

2250.70

u/ml

—

(3002030) Lymphocytes/Leukocytes in Blood

1261

9086

1.77

42.47

10.2

6.4

25.93

28.31

11.48

1223

8585

(3022096) Basophils/Leukocytes in Blood

1229

8799

1.77

42.24

10.3

6.6

0.65

0.68

1.29

1187

8207

(3033658) Prothrombin time (PT) actual/Normal

762

4767

1.85

40.90

6.1

3.8

84.37

93.22

16.41

744

4670

(3018010) Neutrophils/Leukocytes in Blood

1229

8903

1.74

39.64

10.0

6.3

59.15

56.78

10.35

1203

8489

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

339

3.79

39.45

1.5

—

(3036489) Thrombin time

179

622

3.02

38.91

4.2

2.0

21.21

20.64

0.53

165

564

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

722

4521

1.83

38.17

3.0

2.2

2.90

2.69

mg/l

1.32

633

3846

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

236

967

2.59

37.50

16.6

8.5

24.32

24.13

mmol/l

0.40

226

948

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

148

475

3.25

36.80

4.9

2.5

3.73

3.52

g/l

0.72

140

458

(3027945) Reticulocytes/Erythrocytes in Blood

379

1942

2.12

35.81

3.1

2.6

1.77

1.69

0.76

344

1711

(3018418) pH of Serum or Plasma

827

5489

1.75

35.38

7.4

3.8

7.40

0.41

610

3829

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

143

462

3.22

35.16

1.5

1.3

11.62

9.38

iu/ml

—

(3024354) Oxygen [Partial pressure] in Venous blood

296

1390

2.28

34.72

5.6

3.2

4.74

4.51

kpa

1.16

284

1349

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

135

5.30

34.58

1.4

1.3

88.33

82.40

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

333

1646

2.18

34.44

2.7

2.2

390.87

379.99

nmol/l

0.37

302

1528

(3013650) Neutrophils [#/volume] in Blood by Automated count

1405

10823

1.67

33.93

13.7

9.8

4.42

4.12

e9/l

4.09

1223

9329

(3048929) Epstein Barr virus Ab [Presence] in Serum

180

680

2.77

33.53

1.5

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

225

954

2.49

33.19

5.1

3.3

1.80

1.38

mmol/l

0.73

175

675

(3037522) Nuclear Ab [Titer] in Serum

433

2394

1.97

33.00

1.5

1.3

440.42

517.86

titre

0.64

486

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

184

709

2.72

32.98

2.0

1.6

1.54

1.50

g/l

0.21

157

611

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

163

599

2.84

31.97

1.3

—

(3009343) pH of Capillary blood

244

1094

2.36

31.78

5.4

3.4

7.41

7.42

0.16

216

891

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

279

3.73

31.65

1.4

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

226

4.04

31.39

1.5

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

247

1126

2.32

30.95

5.5

3.4

5.20

5.10

kpa

0.84

236

1075

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

101

285

3.65

30.68

1.5

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

257

1217

2.24

29.38

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

226

1015

2.35

29.27

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

213

944

2.37

28.42

18.8

9.2

16.23

16.33

0.20

205

908

(3042733) HLA Ab [Presence] in Serum

6.98

27.58

5.4

4.6

—

(3052851) Hemolysis interference index of Serum or Plasma

125

438

2.95

26.72

4.4

3.0

2.00

2.43

index

0.42

226

(3008152) Bicarbonate [Moles/volume] in Arterial blood

210

950

2.32

26.70

9.7

6.7

24.70

24.36

mmol/l

0.57

201

908

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1103

8317

1.58

26.60

4.7

2.8

151.01

138.81

ug/l

0.77

1046

7743

(3042936) Bacteria identified in Isolate by Culture

424

2493

1.84

26.32

2.4

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

166

684

2.53

25.93

2.1

1.7

8.27

6.58

iu/ml

0.29

162

(3024561) Albumin [Mass/volume] in Serum or Plasma

1105

8379

1.56

25.72

7.4

4.8

34.63

36.09

g/l

11.82

1026

7818

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

164

4.23

25.71

1.5

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

471

2.83

25.59

1.3

1.1

4.78

3.65

0.73

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

122

433

2.91

25.49

1.8

1.7

—

(3024932) HLA-DR beta [Type]

6.81

25.06

1.1

—

(3024471) HLA-A [Type]

6.81

25.06

1.0

—

(3002582) Erythrocytes [#/volume] in Urine

847

6080

1.59

24.79

4.6

3.2

40.17

96.85

e6/l

1.61

687

4600

(3030467) Casts [#/volume] in Urine by Automated count

749

5237

1.61

24.41

4.4

3.1

0.45

0.42

e6/l

0.18

585

3786

(3023520) Reticulocytes [#/volume] in Blood

278

1455

2.02

24.35

3.0

2.7

71.09

66.86

e9/l

1.02

195

1057

(3017143) Hepatitis C virus Ab [Presence] in Serum

392

2305

1.83

24.18

2.0

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

147

4.30

23.98

1.5

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

266

1384

2.03

23.67

3.2

2.6

64.68

67.13

g/l

4.39

240

1264

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

132

513

2.66

23.23

2.7

3.1

67.98

67.33

mg/l

0.01

102

438

(3034860) Kappa light chains.free [Mass/volume] in Serum

132

514

2.65

23.14

2.7

3.1

85.07

146.46

mg/l

0.24

105

439

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

198

3.71

22.75

8.0

5.9

11.33

11.21

mg/l

0.07

185

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

134

531

2.61

22.68

1.4

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

207

3.60

22.06

2.3

2.4

34.76

34.11

iu/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

193

915

2.20

21.87

3.7

4.31

4.65

pmol/l

4.59

169

820

(3007853) Bacteria identified in Skin by Aerobe culture

350

2048

1.82

21.80

2.2

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

268

1440

1.96

21.71

2.3

2.7

10.61

10.67

g/l

0.07

248

1324

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

249

3.33

21.63

1.1

4.04

3.67

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

317

3.04

21.52

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

317

3.04

21.52

1.4

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

864

6399

1.53

21.25

3.7

3.3

43.65

37.73

u/l

0.66

814

6037

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

809

5915

1.54

21.07

3.6

2.6

58.87

61.11

u/l

0.35

762

5472

(40760888) Immunoglobulin light chains.free panel - Serum

343

2.93

21.02

2.5

3.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

280

1549

1.91

20.77

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

533

3556

1.63

20.51

2.2

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

149

651

2.37

20.48

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

202

1002

2.10

20.38

5.5

3.1

127.81

130.98

g/l

1.05

197

970

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

114

4.45

20.35

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

116

452

2.64

20.32

2.7

3.1

6.48

2.74

ratio

0.43

263

(3026782) Osmolality of Urine

541

3633

1.62

20.24

3.7

2.8

519.28

553.16

mosm/kgh2o

3.33

487

3159

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

238

1257

1.99

20.22

7.3

3.7

118.95

78.72

ng/l

4.03

214

1101

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

468

3036

1.66

20.07

3.7

3.0

2.60

2.09

e6/l

0.66

240

1448

(3023183) Ammonium ion [Moles/volume] in Plasma

100

364

2.82

19.98

2.8

2.9

31.78

36.78

umol/l

0.98

333

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

356

2147

1.76

19.93

2.9

8.62

8.77

umol/l

0.04

320

1909

(3000850) Epithelial cells [#/volume] in Urine

600

4145

1.59

19.90

3.7

2.5

4.76

4.83

e6/l

0.07

565

3752

(3023199) Leukocytes [#/volume] in Pleural fluid

121

4.28

19.74

1.6

1.2

1594.15

10213.95

e6/l

0.62

(36304419) Bacteria [Presence] in Urine

702

5037

1.54

19.66

4.3

3.0

—

0.00

estimate

—

(3028026) IgM [Mass/volume] in Serum or Plasma

217

1122

2.02

19.56

1.6

1.9

1.38

1.41

g/l

0.06

199

1034

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

3.11

19.43

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

439

2823

1.67

19.42

2.0

1.6

—

(3045788) Cell count panel - Pleural fluid

4.74

19.39

1.6

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

637

4490

1.56

19.27

3.0

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

492

3266

1.63

19.18

3.7

2.9

1.45

1.10

e6/l

0.67

267

1676

(3018095) Leukocytes [#/volume] in Urine

912

6950

1.49

19.04

5.5

3.8

81.48

89.54

e6/l

0.15

698

4842

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

4.56

18.92

1.4

1.5

—

(1616796) Gas panel - Central venous blood

337

2.83

18.75

5.0

3.0

—

(3022313) Gas panel - Capillary blood

165

794

2.15

18.00

5.8

3.5

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

105

415

2.60

17.90

1.3

1.2

—

9.22

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

678

2.24

17.81

2.2

1.9

—

(3044640) Blood type and Crossmatch panel - Blood

794

5948

1.49

17.77

3.1

2.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

110

4.24

17.65

1.6

1.2

73490.00

71374.76

e6/l

0.01

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.06

17.61

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

122

3.99

17.00

1.3

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

123

537

2.36

16.95

2.4

2.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

170

850

2.07

16.78

6.0

3.0

1.31

1.32

0.04

170

845

(3018333) Ribosomal P Ab [Presence] in Serum

119

4.00

16.73

1.3

1.1

—

(40758558) Short blood count panel - Blood

749

5600

1.48

16.73

9.7

6.2

—

(4268621) Lupus anticoagulant assay

190

3.32

16.69

2.4

2.3

—

(3004451) EKG impression Narrative

5.05

16.67

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

137

632

2.23

16.60

5.8

3.7

24.89

24.63

mmol/l

0.41

126

587

(3024928) Oxygen saturation in Venous blood

383

2.59

16.59

5.1

3.6

68.59

59.68

3.46

366

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

271

2.90

16.41

1.3

1.2

4.80

3.01

u/ml

0.28

118

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

294

1773

1.74

16.32

2.4

2.3

0.20

0.22

g/l

2.59

272

1670

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

124

3.84

15.83

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

124

3.84

15.83

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

124

3.84

15.83

1.6

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

129

3.77

15.75

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

129

3.77

15.75

1.3

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

272

2.85

15.72

1.4

1.2

1.57

3.51

u/ml

1.12

(3031040) Bacteria [#/volume] in Urine by Automated count

1424

12060

1.41

15.71

5.4

4.2

1471.54

1937.55

e6/l

0.14

180

(3012441) Differential panel - Pleural fluid

107

4.07

15.68

1.7

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

650

4776

1.48

15.66

3.9

2.5

366.25

343.36

umol/l

5.22

584

4258

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

125

3.81

15.65

1.3

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

149

3.54

15.55

4.6

2.9

15.09

11.55

index

1.28

(3021589) Normoblasts [#/volume] in Blood

1051

8467

1.41

15.35

17.8

10.1

0.00

e9/l

0.20

833

6865

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

132

3.69

15.25

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

134

636

2.17

15.15

2.0

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

129

3.69

14.98

1.3

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

387

2.48

14.77

2.9

2.0

128.75

131.92

g/l

0.55

292

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.22

14.59

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

111

496

2.29

14.53

1.2

40.73

34.69

u/ml

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1677

14710

1.41

14.50

11.8

7.7

80.37

80.06

u/l

0.09

1614

13905

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.23

14.37

1.1

—

(3026008) Bacteria identified in Urine by Culture

678

5097

1.45

14.31

3.5

3.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

346

2.54

14.19

1.6

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

150

3.38

13.96

1.3

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

221

1283

1.79

13.94

2.5

17.42

21.22

au/ml

0.31

133

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

106

473

2.29

13.93

1.2

4.73

2.13

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.16

13.93

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

290

1818

1.67

13.89

3.1

2.5

39.82

67.94

u/l

0.53

254

1567

(3013512) EKG study

767

5947

1.41

13.52

4.9

2.9

—

0.72

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

206

1185

1.80

13.39

1.4

1.3

40.10

57.19

au/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

105

475

2.26

13.37

1.2

26.33

13.13

u/ml

0.50

(3028271) Lactate [Moles/volume] in Capillary blood

223

2.87

13.34

2.0

1.6

1.73

1.75

mmol/l

0.04

216

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

232

1392

1.73

13.05

3.5

2.6

54.49

70.87

ml/min/173m2

5.89

588

(3024980) IgG subclass 4 [Mass/volume] in Serum

309

2.54

12.80

1.7

0.83

0.82

g/l

0.03

245

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1038

8532

1.37

12.66

3.2

2.7

—

estimate

—

(40760892) CBC W Ordered Manual Differential panel - Blood

572

4257

1.44

12.50

6.1

4.7

—

(3003181) Sodium [Moles/volume] in Urine

289

2.57

12.49

1.3

52.52

65.48

mmol/l

1.88

230

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

103

476

2.21

12.48

1.2

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

151

3.22

12.46

1.2

1.3

98.00

201.88

titre

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

315

2.49

12.31

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

117

574

2.09

12.19

7.4

3.9

1.80

1.35

mg/l

4.30

108

533

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

170

3.04

12.03

3.7

4.5

—

(40768446) Kidney Pathology biopsy report

4.23

11.98

2.1

1.6

—

(40768806) Pleura Pathology biopsy report

115

3.52

11.96

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

280

2.54

11.74

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

107

516

2.12

11.67

1.4

1.2

—

(3012501) Base excess in Blood by calculation

318

2.43

11.59

5.1

3.2

2.53

2.29

mmol/l

0.34

203

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

665

1.97

11.41

2.2

3.73

3.76

g/l

0.09

112

602

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

124

638

1.99

11.36

1.5

1.6

4.49

0.19

iu/ml

0.47

104

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

666

1.97

11.36

2.2

7.39

7.35

g/l

0.10

113

602

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

128

666

1.97

11.36

2.2

4.18

4.22

g/l

0.20

113

603

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

116

585

2.03

11.24

2.2

2.3

10.08

10.26

g/l

0.15

517

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

361

2.31

11.18

1.2

1.1

10.76

39.68

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

357

2.31

11.02

1.5

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

299

2.41

10.71

1.1

16.39

16.87

au/ml

0.01

(37208534) Antinuclear antibody arbitrary concentration in serum

4.74

10.70

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

501

3734

1.43

10.67

1.5

2.51

2.45

g/l

0.35

334

2352

(3016650) Hepatitis A virus Ab [Presence] in Serum

309

2.37

10.42

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.71

10.41

1.3

1.2

36.59

23.82

u/l

0.39

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1573

14008

1.32

10.18

5.6

4.0

13.90

10.75

mm/h

11.02

1474

13054

(3020876) Protein [Mass/time] in 24 hour Urine

171

2.84

10.12

2.6

2.5

1.41

1.63

g/24h

0.18

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

314

2.33

10.06

1.7

—

(3034426) Prothrombin time (PT)

4.81

10.00

1.1

1.2

27.73

28.91

0.34

(3014148) Varicella zoster virus Ab [Titer] in Serum

243

2.50

9.86

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

185

2.74

9.84

1.5

1.2

7.55

6.61

g/l

0.96

131

(3035880) pH of Pleural fluid

4.39

9.79

1.3

1.1

7.43

7.38

0.84

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.80

9.76

1.2

1.1

—

(4035726) Immunohistochemistry procedure

242

1591

1.58

9.49

1.7

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.81

9.49

1.7

2.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

123

3.12

9.48

1.4

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.97

9.31

1.2

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.97

9.31

1.2

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

185

2.68

9.29

1.5

1.2

2.96

3.13

g/l

0.29

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

185

2.68

9.29

1.5

1.2

0.41

0.36

g/l

0.38

130

(4062490) Immunoglobulin typing, IgG

180

2.70

9.22

1.5

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

198

2.61

9.16

1.8

1.3

0.55

0.18

nmol/l

0.49

159

(3007930) Methemoglobin/Hemoglobin.total in Blood

119

656

1.85

8.93

8.1

5.3

0.91

0.89

0.21

112

620

(3019309) Folate [Moles/volume] in Red Blood Cells

414

3073

1.41

8.89

1.9

1.7

1147.38

1126.40

nmol/l

0.18

323

2351

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

622

1.87

8.84

2.3

3.18

2.89

g/l

1.78

559

(3037756) Immunofixation for Serum or Plasma

328

2.20

8.71

1.4

1.6

—

(3047181) Lactate [Moles/volume] in Blood

470

1.99

8.67

7.7

6.4

1.40

1.32

mmol/l

0.29

410

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

192

2.58

8.66

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

130

2.95

8.65

2.7

2.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.33

8.61

1.2

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

104

556

1.91

8.59

1.2

1.3

68.75

106.83

titre

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

125

709

1.80

8.57

9.6

1.4

3.05

5.49

mg/l

1.45

116

511

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

265

1819

1.51

8.54

4.3

2.9

—

(4195642) Thrombophilia screening test

256

2.34

8.40

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

113

626

1.84

8.37

1.3

1.2

0.17

1.12

u/ml

1.33

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

126

726

1.77

8.21

7.5

5.1

1.90

1.59

0.47

119

689

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.22

8.21

1.2

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.32

8.06

1.7

3.3

150.08

117.98

umol/l

0.23

(3010813) Leukocytes [#/volume] in Blood

2025

21357

0.74

7.92

40.5

20.1

7.21

6.69

e9/l

11.01

1982

20744

(3000963) Hemoglobin [Mass/volume] in Blood

2026

21355

0.74

7.77

40.8

20.2

134.44

138.04

g/l

19.38

2006

21071

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2026

21351

0.74

7.71

42.1

20.4

40.32

41.41

3.18

2003

21045

(3026361) Erythrocytes [#/volume] in Blood

2026

21349

0.74

7.68

40.4

20.0

4.48

4.57

e12/l

12.76

1980

20744

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2026

21348

0.75

7.67

40.3

20.0

91.15

90.84

2.22

2004

21051

(3035941) MCH [Entitic mass]

2026

21347

0.75

7.65

40.3

20.0

30.32

30.37

0.57

2004

21051

(3024891) Influenza virus A+B Ag [Presence] in Specimen

514

1.88

7.61

1.3

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

388

2.01

7.58

2.2

3.3

59.50

57.41

0.86

388

(3007461) Platelets [#/volume] in Blood

2026

21339

0.75

7.54

40.4

20.1

249.61

249.18

e9/l

0.10

1989

20800

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.50

7.54

1.2

1.1

168.94

220.51

iu/ml

0.48

(3030981) Hyaline casts [#/volume] in Urine by Automated count

224

1524

1.51

7.53

3.3

2.4

0.26

0.43

e6/l

0.72

216

1453

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

270

2.21

7.45

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.31

7.18

7.5

6.2

6.54

5.35

kpa

0.64

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

20.06

7.13

1.3

1.0

—

(3022145) Colonoscopy Study observation

297

2164

1.42

7.03

1.6

1.4

—

(3000494) Fungus identified in Specimen by Culture

309

2270

1.41

6.98

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

332

2473

1.39

6.92

2.7

206.50

143.39

ug/g

1.71

269

2012

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.79

6.80

2.4

2.8

0.61

0.62

mmol/l

0.36

(3005322) IgE [Units/volume] in Serum or Plasma

180

1195

1.54

6.79

1.4

1.3

293.43

247.78

u/ml

0.26

167

1108

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

103

593

1.77

6.78

2.2

2.3

0.47

1.32

g/l

2.32

506

(1761868) Lipid panel - Serum or Plasma

664

7918

0.78

6.77

3.3

3.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

520

1.82

6.75

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

186

2.39

6.70

8.3

5.5

6.31

7.56

mmol/l

2.63

157

(3035715) Granulocytes [#/volume] in Blood

324

2.03

6.64

2.1

3.5

4.51

3.96

e9/l

1.21

324

(3025941) Bacteria identified in Stool by Culture

152

979

1.59

6.55

1.4

1.2

—

(3015736) pH of Urine

935

8076

1.25

6.53

4.2

3.2

6.25

6.20

0.70

520

4583

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.02

6.49

1.1

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

189

2.35

6.48

1.8

1.3

—

nmol/l

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

260

2.14

6.46

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

442

1.86

6.37

2.1

2.5

0.00

g/l

-0.00

417

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1824

19379

0.79

6.36

6.0

5.4

2.59

2.77

mmol/l

15.12

1718

18050

(40768797) Stomach Pathology biopsy report

333

2516

1.37

6.35

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

495

1.81

6.29

2.1

2.4

0.01

0.04

g/l

0.53

444

(3000093) Morphology [Interpretation] in Blood Narrative

167

2.42

6.28

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

237

1694

1.44

6.23

5.3

4.5

1.08

0.89

0.60

106

505

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

5.03

6.17

1.2

5.98

7.74

pmol/l

—

(3011412) CD3 cells [#/volume] in Blood

163

2.41

6.12

2.3

2.7

1082.00

1309.94

e6/l

0.72

140

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

116

2.69

6.08

2.1

2.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

176

2.35

6.07

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

176

2.35

6.07

1.1

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.60

6.03

1.2

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

484

1.78

5.86

2.1

2.4

0.01

0.00

g/l

0.49

419

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

410

3238

1.32

5.81

1.4

1.3

48.69

31.37

iu/ml

0.71

119

956

(3028433) Virus identified in Specimen by Culture

3.62

5.75

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

473

1.78

5.71

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

228

2.13

5.61

1.4

—

(3037121) Protein [Mass/volume] in Urine

101

612

1.68

5.60

3.8

3.7

434.47

421.39

mg/l

0.03

295

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.20

5.59

1.6

2.0

257.40

808.14

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.20

5.59

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.41

5.58

2.0

2.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.41

5.58

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.41

5.58

2.0

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

963

8450

1.22

5.57

3.0

2.4

74.93

76.50

nmol/l

0.95

879

7647

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

522

4278

1.28

5.56

1.3

2.70

1.70

u/ml

0.53

120

1144

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1790

18969

0.81

5.46

5.4

4.7

1.35

1.42

mmol/l

9.94

1679

17626

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

16.04

5.41

7.3

4.2

100.38

100.00

g/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1803

19085

0.81

5.39

5.4

4.8

4.41

4.66

mmol/l

21.84

1699

17851

(3017704) Immunofixation for Urine

2.87

5.35

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.88

5.34

5.6

7.9

5.26

6.24

mmol/l

0.41

(3044927) Protein electrophoresis panel - Urine

168

2.28

5.30

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.29

5.30

1.2

1.1

—

(3039000) Anion gap in Blood by calculation

325

1.90

5.22

9.6

7.9

11.60

11.34

mmol/l

0.16

290

(3018572) Chloride [Moles/volume] in Blood

325

1.90

5.22

9.6

7.9

104.00

105.47

mmol/l

1.04

290

(3035350) Ketones [Presence] in Urine by Test strip

1126

10094

1.21

5.10

4.7

3.6

13.83

5.47

estimate

0.39

221

2110

(3004616) Nuclear Ab [Presence] in Serum

211

2.10

5.05

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

219

1605

1.40

5.03

5.1

4.4

0.69

0.66

0.09

463

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

226

2.05

4.97

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1130

10155

1.20

4.93

4.7

3.6

0.00

0.01

estimate

2.20

200

1968

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1530

14142

1.21

4.93

4.6

3.9

14.94

14.72

pmol/l

2.87

1423

12882

(3024522) Salmonella sp identified in Specimen by Organism specific culture

227

2.04

4.91

1.4

—

(3008295) Osmolality of Serum or Plasma

195

2.12

4.82

1.2

1.4

283.00

281.78

mosm/kgh2o

0.07

147

(3014051) Protein [Presence] in Urine by Test strip

636

5414

1.23

4.79

3.5

2.8

0.00

0.04

—

133

(3036525) Urea [Moles/time] in 24 hour Urine

11.46

4.78

1.9

3.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

224

2.03

4.71

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

224

2.03

4.71

1.4

—

(3000012) Reticulocyte production index

224

2.03

4.71

1.9

2.0

0.94

0.83

0.35

155

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

949

8419

1.20

4.69

2.2

2.0

93.70

95.15

pmol/l

0.44

530

4503

(3015377) Calcium [Moles/volume] in Serum or Plasma

744

6449

1.22

4.68

4.8

3.5

2.34

2.36

mmol/l

4.14

680

5865

(3005988) Vibrio sp identified in Specimen by Organism specific culture

226

2.01

4.60

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.53

4.55

1.2

92.78

85.86

—

(3021601) Nitrite [Presence] in Urine by Test strip

1104

9975

1.19

4.36

4.7

3.6

0.00

estimate

0.50

216

2079

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.02

4.31

1.2

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.60

4.30

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

11.69

4.27

6.4

7.2

570.86

559.33

umol/l

—

(3042631) Mycobacterium sp identified in Specimen

226

1.96

4.25

2.1

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

610

5227

1.22

4.25

1.9

1.6

18.39

20.10

nmol/l

2.37

530

4409

(3044242) Glucose [Moles/volume] in Arterial blood

2.63

4.22

1.8

2.2

7.49

7.37

mmol/l

0.06

(3004809) Band form neutrophils/Leukocytes in Blood

298

1.83

4.22

2.9

3.8

1.86

1.22

0.82

262

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

146

2.21

4.21

1.0

1.1

12.57

18.94

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.82

4.18

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

228

1.95

4.16

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

2.81

4.12

1.1

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

174

2.08

4.11

1.7

1.5

1.19

1.26

promille

0.09

144

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

178

2388

0.73

4.11

1.8

2.0

3.79

3.65

ratio

0.58

132

1852

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.63

4.05

1.1

92.50

96.85

0.20

(3021440) Promyelocytes/Leukocytes in Blood

214

1623

1.35

4.02

5.6

4.5

0.08

0.12

0.63

436

(40758047) Lysozyme [Mass/volume] in Pleural fluid

10.02

4.01

1.0

11.00

14.54

mg/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.21

4.01

1.2

1.1

88.38

84.86

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

718

8140

0.84

4.00

1.9

1.47

1.40

mmol/l

1.10

618

6966

(3050794) Legionella sp Ab [Presence] in Serum

6.44

3.98

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

561

6497

0.82

3.92

3.8

4.4

21.83

21.73

0.05

231

3096

(3028679) Herpes simplex virus Ab [Presence] in Serum

106

2.37

3.90

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.80

3.89

1.3

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.97

3.84

5.9

2.6

4.86

4.82

kpa

0.06

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.97

3.84

5.9

2.6

9.98

10.35

kpa

0.26

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.54

3.79

1.4

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.54

3.79

1.4

1.9

—

(3026480) Teichoate Ab [Titer] in Serum

8.77

3.77

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

188

1414

1.36

3.74

6.9

3.6

1.22

1.23

mmol/l

1.46

168

1209

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

455

1.62

3.74

2.1

2.0

2.73

4.04

iu/l

1.59

201

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

325

1.74

3.74

1.2

1.3

13.90

34.57

u/l

1.66

269

(4198724) Urine methamphetamine measurement

2.41

3.72

1.6

1.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

2.58

3.71

2.6

1.6

205.05

148.00

1.60

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

414

4911

0.81

3.66

2.9

3.1

0.77

0.80

ug/l

0.21

257

3055

(3010838) Calcium [Moles/time] in 24 hour Urine

290

1.77

3.66

1.6

2.0

4.30

5.19

mmol/24h

1.24

254

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.79

3.56

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.79

3.56

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.51

3.54

1.7

2.8

1.70

1.15

0.52

(3019225) pH of Specimen

225

1755

1.31

3.50

6.6

3.8

7.37

7.34

1.03

187

1258

(3003327) Ova and parasites identified in Stool by Light microscopy

664

1.49

3.50

1.8

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.38

3.48

1.3

1.2

1.08

1.06

ratio

0.43

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.53

3.40

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

507

1.56

3.38

1.3

1.1

—

(3014891) Appearance of Pleural fluid

7.01

3.36

1.4

—

(3045142) Bone marrow Pathology biopsy report

189

1.92

3.33

1.1

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.72

3.32

1.3

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

121

2.16

3.32

2.7

2.9

458.10

642.27

e6/l

0.93

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

141

2.07

3.32

3.3

2.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.43

3.31

1.2

1.7

—

(3017569) Oxygen content in Arterial blood

2.42

3.30

2.0

2.5

15.27

16.90

1.49

(42529406) Shigella sp [Presence] in Stool by Culture

512

1.54

3.25

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.79

3.25

2.3

2.4

0.29

0.14

e9/l

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.54

3.19

2.0

1.18

1.19

mmol/l

0.20

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.18

3.19

1.3

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

6.38

3.18

1.0

17.57

6.00

u/l

—

(4015189) Microbial culture of sputum

3.80

3.18

1.7

2.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

507

1.53

3.18

1.3

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

132

1777

0.73

3.15

1.4

1.7

3.50

3.53

mmol/l

0.08

1228

(3044290) Cell count panel - Cerebral spinal fluid

436

1.57

3.15

1.9

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

201

1.85

3.11

1.7

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

719

8016

0.86

3.11

4.3

5.3

1.84

3.24

ug/l

2.08

645

7329

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.44

3.10

1.5

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

195

1.86

3.06

1.7

1.5

56.29

56.12

0.01

124

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.51

3.05

4.2

2.1

—

(21494434) Karyotype in Bone marrow

133

2.04

3.01

1.1

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

211

1.81

3.00

2.1

1.9

27.83

23.41

mg/l

0.21

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.30

2.99

1.2

1.0

103.11

88.38

titre

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

10.01

2.98

4.2

6.2

1.19

0.90

g/l

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

10.01

2.98

1.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.01

2.98

1.0

—

(3025159) Blasts/Leukocytes in Blood

206

1627

1.29

2.96

5.6

4.8

0.00

0.09

3.89

395

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

134

2.03

2.95

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1721

17991

0.86

2.94

4.8

4.0

1.37

1.32

mmol/l

1.86

1606

16548

(3019832) Treponema pallidum Ab [Presence] in Serum

218

1736

1.28

2.94

2.3

1.9

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1983

20506

0.85

2.93

17.0

10.9

31.08

27.88

u/l

2.05

1933

19867

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

485

1.52

2.92

1.8

1.2

3.78

3.75

mmol/l

0.09

464

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

356

3002

1.22

2.88

1.3

7.87

11.84

u/ml

0.63

125

1175

(3020961) Endomysium IgA Ab [Titer] in Serum

119

874

1.38

2.82

1.1

600.00

168.81

titre

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

123

2.04

2.81

2.8

3.0

230.89

223.70

e6/l

0.05

102

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

132

1.98

2.70

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

257

2111

1.24

2.68

11.0

5.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.22

2.67

3.6

2.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.18

2.67

1.8

1.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

172

1348

1.30

2.65

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.15

2.64

1.3

1.2

1.16

1.17

mmol/l

0.14

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

464

1.50

2.64

2.1

1.4

36.04

21.50

e6/l

0.21

346

(3000475) Leukocytes [#/volume] in Synovial fluid

440

1.51

2.63

2.1

1.7

16022.80

13139.76

e6/l

0.36

298

(3000330) Specific gravity of Urine by Test strip

117

868

1.36

2.62

4.4

3.4

1.02

ratio

2.61

103

789

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.16

2.60

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

148

1.90

2.60

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

149

1148

1.32

2.60

1.2

106.79

124.76

u/ml

0.24

419

(3023410) Appearance of Cerebral spinal fluid

214

1.74

2.59

2.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

107

2.06

2.57

1.6

2.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.01

2.56

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

3.06

2.56

1.4

1.9

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.43

2.53

1.5

1.7

28.47

29.81

0.10

(3017732) Neutrophils [#/volume] in Blood

278

2318

1.22

2.53

3.6

3.4

5.04

4.71

e9/l

0.17

247

2002

(3000570) Elastase.pancreatic [Mass/mass] in Stool

561

1.44

2.49

1.5

1.4

246.75

276.45

ug/g

0.74

330

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

545

1.44

2.48

1.8

1.3

506.42

560.59

mg/l

0.49

524

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.38

2.47

2.0

4.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

398

1.52

2.46

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.56

2.44

1.2

1.1

87.00

91.96

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.13

2.43

2.1

2.4

1.19

mmol/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

473

1.47

2.43

2.2

1.5

2715.16

940.49

e6/l

0.65

370

(3003740) Influenza virus B Ag [Presence] in Specimen

400

1.51

2.41

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

227

1.68

2.40

2.2

2.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

634

1.40

2.38

1.4

1.5

8.78

7.81

u/l

0.28

525

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

322

2741

1.20

2.38

1.9

1.8

1.57

1.48

1.21

278

2455

(3049717) Cytology report of Urine Cyto stain

729

1.37

2.36

2.0

2.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.51

2.35

1.0

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

161

1.81

2.35

1.7

1.5

25.45

29.93

0.24

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1767

18342

0.88

2.34

5.4

4.8

6.03

5.93

mmol/l

1.76

1630

16836

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

1.80

2.31

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.12

2.28

2.2

1.8

169.78

99.17

ng/l

0.46

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

293

1.58

2.28

8.9

2.9

12.05

7.81

pmol/l

1.63

293

(3002079) Sodium [Moles/time] in 24 hour Urine

2.23

2.27

1.0

1.3

132.44

186.41

mmol/24h

1.82

(3028707) Methadone [Presence] in Urine by Screen method

424

1.47

2.23

3.0

2.8

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.56

2.21

1.4

1.9

—

(3014271) Vancomycin [Susceptibility]

2.20

2.21

3.2

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.41

2.19

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

168

2074

0.80

2.17

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.01

2.14

1.1

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.37

2.12

1.6

2.3

654.88

475.28

e6/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

228

1.63

2.11

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.21

2.09

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

2.08

2.06

1.3

1.7

—

2789.33

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.11

2.02

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.51

2.01

1.7

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.51

2.01

1.3

—

(3024263) Appearance of Synovial fluid

2.01

2.00

1.4

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1417

13482

1.11

2.00

4.0

3.2

60.87

48.49

u/l

4.07

1339

12690

(3016018) Differential panel - Cerebral spinal fluid

240

1.59

1.98

2.2

1.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2019

20714

0.87

1.98

35.0

16.7

88.26

77.86

umol/l

11.91

1999

20421

(3036071) Salmonella sp Ab [Titer] in Serum

2.15

1.98

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

119

1.86

1.97

1.0

1.1

9.14

5.36

iu/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.36

1.94

1.2

83.57

97.15

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.19

1.94

1.1

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.97

1.93

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

3.75

1.93

9.0

6.9

10.93

10.82

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

172

1.69

1.93

1.1

1.3

2.18

2.10

mmol/l

0.12

166

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

120

1.84

1.92

1.5

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

825

7633

1.12

1.92

4.5

3.5

0.00

0.03

estimate

5.17

193

1708

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

861

0.71

1.90

1.0

1.1

1.44

1.48

g/l

0.59

861

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.01

1.90

2.8

4.1

—

(40768800) Prostate Pathology biopsy report

541

0.64

1.87

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.94

1.84

1.2

1.1

1104.33

1516.45

miu/ml

1.43

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.21

1.84

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

115

1.83

1.82

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

1.83

1.82

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

138

1.75

1.79

1.7

6.63

6.49

mmol/l

0.12

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

2.76

1.79

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.17

1.77

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

116

916

1.28

1.77

1.6

1.7

0.36

0.32

mg/l

0.36

456

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

147

1.71

1.73

1.4

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

2.2

4.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.14

1.71

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

656

1.32

1.71

1.7

297.94

286.09

mu/l

0.08

604

(3011985) Renin [Units/volume] in Plasma

250

1.53

1.70

2.0

1.5

85.12

48.22

mu/l

0.47

223

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

433

1.39

1.69

3.1

1.9

0.95

0.82

nmol/l

0.60

377

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

111

1.81

1.68

2.1

2.8

44.18

40.73

0.38

(40765096) Chromosome analysis panel by Banding

2.19

1.67

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.19

1.67

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.03

1.64

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.93

1.64

3.0

2.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

462

1.37

1.62

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.58

1.61

1.6

138.60

259.79

umol/24h

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.58

1.61

1.2

—

(3045414) Leukocytes [Presence] in Urine

200

1695

1.19

1.61

2.6

2.1

0.00

0.01

estimate

0.78

395

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

1.59

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

1.59

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

1.59

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

198

1.57

1.59

5.0

3.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.00

1.58

1.2

2.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

447

0.64

1.57

1.1

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

600

5510

1.12

1.57

5.0

3.7

0.01

0.00

estimate

0.31

193

1906

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

330

1.43

1.56

2.2

1.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1962

19112

1.12

1.54

29.1

13.0

26.05

25.62

mg/l

0.24

1758

15329

(40761536) Microorganisms panel - Urine sediment

175

1473

1.20

1.53

5.0

3.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

459

1.36

1.53

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

104

829

1.26

1.51

3.0

2.1

—

(36660697) Celiac disease serology panel - Serum

173

1457

1.20

1.51

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

1.87

1.50

1.4

1.3

5.63

4.84

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1259

12017

1.09

1.49

3.4

2.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

101

1.79

1.48

1.3

1.1

105.98

78.85

u/l

0.75

(3051387) C reactive protein [Mass/volume] in Capillary blood

427

0.65

1.46

5.4

3.1

24.49

28.07

mg/l

0.27

278

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

413

3726

1.13

1.46

3.9

3.0

2.45

mmol/l

0.35

355

3346

(3002619) Bacteria identified in Specimen by Culture

2.37

1.45

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

592

5456

1.11

1.45

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

102

1.77

1.44

1.3

1.1

36.30

21.57

u/l

0.81

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

1.69

1.43

1.2

111.05

113.20

pmol/l

0.07

125

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

109

881

1.25

1.43

1.1

—

0.85

—

(3027944) Amphetamines [Presence] in Urine

128

1054

1.23

1.41

2.9

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

129

1064

1.22

1.40

2.8

2.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1.76

1.34

7.0

2.7

28.77

20.57

mu/l

0.37

(3027008) Opiates [Presence] in Urine

129

1070

1.22

1.34

2.8

2.0

—

(3004775) Volume in Urine collected for unspecified duration

136

1.62

1.32

2.7

2.1

716.18

641.30

0.25

(3016879) Cocaine [Presence] in Urine

120

991

1.22

1.31

2.8

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

509

0.70

1.31

1.9

1.6

—

(3028300) Cannabinoids [Presence] in Urine

129

1074

1.21

1.30

2.8

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

784

1.25

1.29

1.3

1.5

29.61

24.60

iu/l

0.65

667

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1779

17301

1.09

1.29

5.6

4.7

1.97

1.89

mu/l

0.44

1665

15885

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

482

1.31

1.29

1.1

1.87

4.29

eliau/ml

—

(3033099) Centromere Ab [Titer] in Serum

2.36

1.29

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.97

1.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.97

1.22

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.97

1.22

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.97

1.22

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

711

1.25

1.19

5.3

2.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

1.18

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

128

1078

1.20

1.17

2.8

2.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

413

1.31

1.13

2.9

2.3

339.32

96.81

ug/min

1.26

245

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

1.65

1.12

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.00

1.12

1.0

11.52

43.66

iu/ml

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1764

18064

0.92

1.12

6.9

5.9

39.44

38.96

mmol/mol

1.35

1673

16908

(3019150) Specific gravity of Urine by Refractometry

484

4476

1.10

1.11

4.8

3.6

1.02

kg/l

0.70

346

2907

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

238

2116

1.14

1.10

2.3

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.26

1.10

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.38

1.09

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

144

1.53

1.08

2.2

2.5

36.29

34.56

mg/l

0.05

103

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

183

2084

0.87

1.07

1.3

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.71

1.05

2.5

2.0

40.20

103.72

ug/min

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

332

1.33

1.03

1.8

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1623

16652

0.93

1.03

34.8

16.8

331.93

333.68

g/l

11.02

1613

16528

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.27

1.03

1.6

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.06

1.02

1.1

1.4

1973.69

24.77

g/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.84

1.02

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

108

910

1.19

1.01

2.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

139

1.51

1.00

1.7

1.4

78.71

84.35

umol/l

0.28

139

(3017509) Phencyclidine [Presence] in Urine

2.18

0.98

1.2

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.18

0.98

1.8

2.7

0.80

0.30

u/field

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

353

1.31

0.97

1.1

1.99

1.98

u/ml

0.00

183

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

1.38

0.97

1.2

1.4

295.96

300.16

pmol/l

0.02

192

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

217

1943

1.13

0.93

4.0

4.6

11.28

23.69

ug/l

1.17

179

1604

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

589

1.23

0.93

1.3

225.12

217.34

miu/ml

0.04

269

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

269

1.34

0.92

1.1

1.0

2.26

eliau/ml

0.00

125

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.82

0.92

1.8

1.5

1631.80

693.18

nmol/24h

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

167

1.44

0.92

2.1

1.3

9141.18

95461.50

e6/l

1.29

108

(3019550) Sodium [Moles/volume] in Serum or Plasma

1990

19548

1.08

0.91

34.1

14.7

139.32

139.70

mmol/l

9.46

1955

19094

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

151

1.46

0.90

3.9

6.1

82.83

37.64

u/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.91

0.88

1.1

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

103

1.56

0.87

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

981

1.17

0.87

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

307

1.31

0.87

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

369

1.28

0.87

1.2

1.1

8.78

5.51

u/ml

0.68

206

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.59

0.84

1.4

1.3

284.14

484.86

u/l

0.69

(3009508) Creatinine [Moles/volume] in Urine

708

6743

1.07

0.80

4.3

3.4

7.17

8.23

mmol/l

8.14

618

5747

(3004716) Salmonella sp identified in Stool by Organism specific culture

104

897

1.17

0.79

1.4

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

123

1.47

0.77

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

583

5534

1.07

0.73

3.9

3.0

0.01

0.02

estimate

0.72

177

1648

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.72

1.2

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.00

0.72

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

2.6

—

(3032057) Clostridioides difficile [Presence] in Stool

1.80

0.72

1.4

2.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.61

0.72

1.3

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.75

0.71

1.1

1.0

7.15

8.93

mg/g

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1991

19613

1.07

0.71

34.6

14.8

3.99

3.98

mmol/l

2.01

1958

19120

(1761482) Bacteria [#/volume] in Urine by Culture

444

1.22

0.71

5.0

4.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.71

0.70

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.69

1.3

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

248

2282

1.10

0.69

2.4

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

226

2460

0.91

0.68

2.5

2.3

14.29

14.00

nmol/l

0.24

207

2271

(3022621) pH of Urine by Test strip

160

1441

1.12

0.67

3.2

2.6

6.01

6.07

0.34

113

949

(3006653) Thiamine [Moles/volume] in Blood

102

1.47

0.67

1.3

139.84

138.02

nmol/l

0.06

102

(3008401) Mugwort IgE Ab [Units/volume] in Serum

358

1.23

0.65

1.2

1.1

1.41

1.30

u/ml

0.05

163

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.61

0.65

1.7

1.5

38.21

41.42

g/l

—

(1002224) Polysomnography panel

115

1019

1.13

0.64

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

163

1.35

0.64

1.1

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

415

3915

1.07

0.63

1.8

1.7

59050874.51

33816843.20

pmol/l

0.23

337

3312

(3026389) Candida sp identified in Specimen by Organism specific culture

207

1.31

0.63

1.6

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

261

1.27

0.62

1.1

1.0

0.07

0.39

u/ml

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

105

0.57

0.61

1.7

23.50

27.40

umol/l

—

(3052592) Norovirus Ag [Presence] in Stool

1.67

0.61

1.0

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.67

0.61

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.50

0.59

1.5

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.58

0.56

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

364

3438

1.07

0.55

1.9

1.5

—

(3045424) Erythrocytes [Presence] in Urine

104

927

1.13

0.55

2.5

2.1

0.04

0.01

estimate

0.29

308

(3009466) Valproate [Moles/volume] in Serum or Plasma

330

1.22

0.54

6.3

5.8

350.80

354.30

umol/l

0.05

293

(40768804) Tissue Pathology biopsy report

776

7500

1.05

0.53

2.3

2.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

649

6248

1.05

0.52

5.4

4.1

19.16

6.16

mg/mmol

5.06

429

3959

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.61

0.52

1.3

1.2

—

(3005570) Glucose [Moles/volume] in Urine

161

1.31

0.51

1.3

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

677

1.14

0.51

1.6

21.48

15.52

u/ml

0.16

169

(3012516) Albumin [Mass/volume] in Urine

635

6122

1.05

0.48

4.5

3.4

94.22

37.76

mg/l

4.93

427

3939

(3014133) Dog dander IgE Ab [Units/volume] in Serum

308

1.20

0.48

1.1

4.22

3.49

u/ml

0.13

157

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

177

0.73

0.47

1.4

1.5

44.74

53.41

ug/l

0.61

177

(3041806) Other cells [#/volume] in Blood by Manual count

1.47

0.47

1.2

1.7

0.71

0.48

e9/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

292

1.20

0.45

1.1

1.73

6.19

u/ml

2.39

131

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

895

1.11

0.44

3.0

2.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

121

1.32

0.44

1.1

0.56

6.03

nmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

113

1.33

0.42

3.6

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.38

0.41

1.3

1.5

8.37

8.57

ug/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

518

0.87

0.40

1.6

989.68

999.08

mu/l

0.02

438

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

79.78

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

429

1.14

0.38

1.2

1.1

1.75

2.03

u/ml

0.11

240

(44806420) Estimation of glomerular filtration rate

179

1.23

0.37

2.5

2.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

116

1.29

0.37

1.1

—

(3008898) HLA-B27 [Presence]

687

1.11

0.36

1.1

—

(40768793) Breast Pathology biopsy report

365

1.15

0.36

1.4

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

146

0.75

0.36

1.5

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

352

0.85

0.35

1.6

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.33

0.33

1.0

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

100

1.30

0.33

3.5

2.3

191.15

151.64

nmol/l

0.51

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.30

0.33

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

219

1.19

0.33

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.35

0.31

1.3

1.4

—

(4024509) Urine culture

787

0.91

0.30

2.8

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

399

0.88

0.30

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

217

0.83

0.29

1.4

153.88

176.34

pmol/l

0.58

217

(3001019) Free T4 and TSH panel - Serum or Plasma

907

1.07

0.25

1.5

1.6

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1630

16147

1.03

0.24

33.6

16.4

13.88

13.50

18.72

1611

15915

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

211

0.85

0.23

1.8

—

(3025577) Chromium [Mass/volume] in Blood

0.75

0.22

2.1

1.89

2.08

ug/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

1.18

0.22

1.4

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

200

1.15

0.22

1.4

1.3

—

(40768443) Skin Pathology biopsy report

787

1.07

0.22

1.1

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

26.47

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

13.34

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

1.9

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

219

2268

0.96

0.20

4.6

31.07

31.73

0.43

166

1460

(1617658) Protocol used for examination of sentinel lymph nodes

115

0.78

0.20

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

249

0.88

0.19

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

226

2187

1.04

0.19

1.6

1.5

—

(3022689) Creatine [Moles/volume] in Urine

1.15

0.17

1.6

1.3

4.83

10.07

mmol/l

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

120

1.17

0.16

1.4

1.2

0.63

0.57

ratio

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

216

1.11

0.15

1.3

23.11

22.89

u/l

0.01

175

(44813793) Dust mix specific IgE antibody measurement

119

0.84

0.15

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

159

0.88

0.13

1.0

670.89

703.20

ng/l

—

101

(4146454) Self-monitoring of blood glucose

190

0.89

0.13

2.9

2.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

312

0.93

0.11

1.6

1.5

52.85

60.17

ug/l

0.33

265

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

172

1.11

0.11

16.9

21.0

1175.16

1398.22

nmol/l

0.83

167

(3025130) Human papilloma virus identified in Specimen

209

0.91

0.11

1.9

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

197

1926

1.02

0.10

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.15

0.10

3.6

3.2

50.73

45.91

0.42

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.15

0.10

7.3

6.3

9.00

7.92

0.19

(3005033) Fetal Nuchal fold Thickness US

238

0.92

0.09

1.4

1.5

1.27

0.01

176

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

164

1.10

0.09

11.6

17.1

808.17

805.39

nmol/l

0.01

159

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.09

0.09

3.0

2.0

2.80

79.89

ug/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

488

1.05

0.09

2.7

2.3

3489.79

4612.75

u/l

0.15

178

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.81

0.08

1.4

2.7

0.99

1.03

ug/l

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.14

0.08

2.0

1.9

1.08

0.84

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.83

0.07

2.5

2.7

—

693.03

—

(4211845) Urine protein measurement

0.86

0.07

2.6

3.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

244

0.94

0.06

1.4

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.11

0.06

1.9

1.5

34.03

24.09

umol/l

0.38

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

223

0.94

0.06

1.5

1.6

—

(4034850) Laboratory test

597

0.97

0.05

18.2

8.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1845

18481

0.99

0.05

26.4

12.8

81.53

83.52

ml/min/173m2

2.86

1726

16923

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

120

1.08

0.04

1.2

1.3

—

77.50

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

129

1271

1.02

0.04

1.2

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

290

0.96

0.03

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

738

1.02

0.03

5.0

3.7

108.54

3371.67

u/ml

1.33

645

(4281824) Cell count and differential, peritoneal fluid

162

1.05

0.02

1.3

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

163

1.04

0.01

1.2

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

237

0.97

0.01

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

327

0.98

0.01

1.3

1.1

1.20

1800.48

iu/ml

—

(40768441) Liver Pathology biopsy report

144

1.04

0.00

1.2

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

316

0.98

0.00

1.8

2.8

43.09

1029.71

u/ml

0.64

311

(3002256) Pathology report gross observation

258

2586

1.00

0.00

1.5

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

202

0.99

0.00

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

145

0.97

0.00

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

177

1.02

0.00

1.2

2.5

5.31

7.64

umol/l

—

128

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

295

0.98

0.00

1.5

0.86

0.95

ratio

0.96

186

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

295

0.98

0.00

1.5

1.23

1.20

ratio

0.09

186

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

295

0.98

0.00

1.5

1.00

1.17

ratio

0.53

186

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

155

1.03

0.00

1.6

2.2

9.18

1.76

u/field

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

105

1.05

0.00

1.4

1.2

10.55

7.70

mm/h

0.34

105

(3045683) HLA typing for celiac disease panel - Blood or Tissue

113

0.97

0.00

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.00

0.00

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.2

—

1.31

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

0.03

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.98

-0.00

1.0

33.40

59.49

u/ml

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.0

—

2.60

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

412.40

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.93

-0.00

1.2

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

0.94

-0.00

1.9

2.1

5.69

3.63

ug/l

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.40

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

1.86

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

0.04

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.97

-0.00

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.94

-0.00

2.8

2.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

172.43

—

(3006462) Nitrate [Presence] in Urine

0.97

-0.00

2.6

3.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

8.21

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.35

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3020650) Glucose [Presence] in Urine

0.93

-0.00

1.4

2.0

0.00

0.08

estimate

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_OTHILLHEART and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.38 [2.04, 2.77]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.038

During the follow-up period (1.1.1998 — 31.12.2019), 1023 out of 3349 females with I9_OTHILLHEART died.

Males

Parameter	HR [95% CI]	p-value
I9_OTHILLHEART	2.371 [2.05, 2.75]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.039

During the follow-up period (1.1.1998 — 31.12.2019), 1115 out of 6178 males with I9_OTHILLHEART died.

Mortality risk

Mortality risk for people of age

years, who have I9_OTHILLHEART.

N-year risk	Females	Males
1	0.213%	0.452%
5	1.362%	2.737%
10	3.343%	6.988%
15	5.763%	13.198%
20	10.061%	21.709%

Relationships between endpoints

↥

Index endpoint: I9_OTHILLHEART – Other or ill-defined heart diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other or ill-defined heart diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints